Skip to main content
Premium Trial:

Request an Annual Quote

CombiChem Appoints Two Scientists to Research Management Positions

Premium

SAN DIEGO--CombiChem, a computational drug discovery company here, has named two scientists to management positions. Klaus Gubernator was appointed vice-president of special projects, and Robert Zambias will be director of chemistry automation. The two are both members of a technology research group led by Steven Teig, CombiChem's vice-president for advanced technology.

Gubernator formerly directed the molecular design and bioinformatics section in pharmaceutical preclinical research at Hoffman-LaRoche's research facility in Basel. Among other things, he led the development and application of structure-based design and bioinformatics technologies there. Zambias was previously at ArQule, where he served as executive director of automated synthesis, leading the design, construction, and implementation of the company's automated chemistry program and forming the company's Automated Synthesis Engineering and Chemistry Groups.

CombiChem uses its proprietary Discovery Engine process to focus on the generation, evolution, and optimization of potential new lead candidates for its collaborative partners, who include Teijin, Roche Bioscience, Sumitomo Pharmaceuticals, ImClone Systems, and Athena Neuroscience.

Filed under

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.